Published • loading... • Updated
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $130.00
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $130.00
Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) had its price objective boosted by Robert W. Baird from $123.00 to $130.00 in a research note issued to investors on Tuesday morning, MarketBeat.com reports. Robert W. Baird currently has an outperform rating on the stock. Several other equities analysts have also recently commented on the stock. Weiss Ratings […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
![[Opinion] Κεμπέκ: Πολιτικός «σεισμός» προ των πυλών καθώς η επαρχία οδεύει προς τις κάλπες](/_next/image?url=https%3A%2F%2Fgrnd.b-cdn.net%2Finterests%2F77552585ba37f97befdabee804828c0b3794ab94.jpg&w=1440&q=75)
